Denmark, Norway and Iceland have suspended the use of AstraZeneca vaccine after cases of blood clots in patients.

But for the European Medicines Agency, the vaccine can continue to be used: "the benefits continue to outweigh the risks".

European countries may continue to use AstraZeneca's coronavirus vaccine, despite the opening of an investigation into cases of blood clots that have prompted Denmark, Norway and Iceland to withhold injections, said Thursday the European medicines regulator.

>> LIVE

 - Coronavirus: follow the evolution of the situation Thursday March 11

The position of the European Medicines Agency Safety Committee "is that the benefits of the vaccine continue to outweigh its risks and that the vaccine can continue to be administered while the investigation of thromboembolism cases is ongoing. "the EMA said in a statement.